Opportunity Information: Apply for RFA DA 23 035

The National Institutes of Health (NIH) funding opportunity RFA-DA-23-035 is an R01 research grant (clinical trial not allowed) focused on building a detailed, large-scale picture of the specific brain cells and cell groups in rodents that either produce opioids, respond to opioids, or become active across different phases of opioid exposure and use. The core idea is to move beyond broad brain-region descriptions and instead identify the actual cell types and cellular ensembles that drive opioid effects and opioid-related behaviors, including acute exposure, chronic exposure, withdrawal, abstinence, and relapse. Projects supported under this announcement are expected to contribute foundational knowledge that can later inform better mechanistic understanding of opioid-associated brain states.

A central emphasis of the FOA is on integrated, multimodal mapping at single-cell resolution. Applicants are encouraged to use scalable and innovative technologies that can inventory and register (meaning systematically identify and align) the relevant cells while also profiling them molecularly, typically through approaches that capture gene expression and related molecular signatures in individual cells. What makes this announcement distinctive is the expectation that molecular profiling should be integrated with other types of measurements collected from the same cells whenever possible. These additional modalities can include neural activity measurements (neurophysiology), connectivity information (how cells are wired into circuits), and spatial localization (where exactly the cells sit within brain structures). In practical terms, the FOA is pushing for datasets where a given cell can be described simultaneously by what it is molecularly, where it is, what it connects to, and how it behaves, rather than having those insights come from separate experiments that cannot be cleanly linked cell-by-cell.

The deliverable that matters most is not only discovery for a single lab, but the generation and dissemination of high-value reference datasets that can be used broadly by the neuroscience and addiction research communities. NIH is looking for resources that function like shared atlases or reference maps: multimodal datasets that other researchers can mine to test hypotheses, compare results across studies, and build a more unified biological framework for understanding opioid action and opioid-related states in the brain. The announcement frames these datasets as foundational infrastructure for the field, with the long-term payoff being clearer cellular and circuit-level targets for future mechanistic work and, eventually, translational progress.

Administratively, this is a discretionary grant under the NIH, categorized under education and health (CFDA 93.279). The original closing date listed is 2023-02-02, and the posted award ceiling is $700,000. The FOA is open to a wide range of applicant types, including state and local governments, public and private institutions of higher education, independent school districts, special district governments, federally recognized tribal governments and other tribal organizations, public housing authorities/Indian housing authorities, nonprofits with or without 501(c)(3) status, for-profit organizations (other than small businesses), and small businesses. The eligible applicant pool is explicitly broad and also highlights additional eligible groups such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISI institutions, Hispanic-serving institutions, HBCUs, Tribally Controlled Colleges and Universities, faith-based or community-based organizations, U.S. territories or possessions, and even non-U.S. (foreign) organizations and regional organizations, indicating NIH is willing to support strong teams wherever they are based as long as they can deliver the type of integrated, shareable science the program is designed to accelerate.

In short, this opportunity is designed to fund ambitious R01-scale efforts that combine cutting-edge single-cell molecular profiling with aligned measurements of activity, connectivity, and/or spatial position in the rodent brain, specifically to identify and characterize the cell types and ensembles that mediate opioid effects and opioid-use stages. The program is geared toward producing community-facing reference resources that help the entire field converge on a clearer cellular and circuit-level understanding of opioid-associated brain biology.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Large Scale Integrated Mapping and Molecular Profiling of Cell Ensembles and/or Cell-Types Mediating Opioid Action in the Rodent Brain (R01 - Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
  • This funding opportunity was created on 2022-09-19.
  • Applicants must submit their applications by 2023-02-02. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $700,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA DA 23 035

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: BJA FY 23 Connect and Protect: Law Enforcement Behavioral Health Response Program

Previous opportunity: NT-22-01: Capacity Building and Collaboration with the Aquinnah and Mashpee Wampanoag Tribes

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DA 23 035

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DA 23 035) also looked into and applied for these:

Funding Opportunity
HEAL Initiative: HEAL Data2Action Acceleration Projects (R33 Clinical Trial Not Allowed) Apply for RFA DA 23 058

Funding Number: RFA DA 23 058
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $750,000
HEAL Initiative: HEAL Data2Action Innovation and Acceleration Projects, Phased Awards (R61/R33, Clinical Trial Optional) Apply for RFA DA 23 057

Funding Number: RFA DA 23 057
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $750,000
Advancing Adolescent Tobacco Cessation Intervention Research (R34 Clinical Trial Optional) Apply for RFA CA 22 042

Funding Number: RFA CA 22 042
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $450,000
Advancing Adolescent Tobacco Cessation Intervention Research (R01 Clinical Trial Required) Apply for RFA CA 22 043

Funding Number: RFA CA 22 043
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $3,150,000
Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U01 Clinical Trial Not Allowed) Apply for RFA CA 22 052

Funding Number: RFA CA 22 052
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Coordinating Center for Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U24 Clinical Trial Not Allowed) Apply for RFA CA 22 053

Funding Number: RFA CA 22 053
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) Apply for RFA CA 22 051

Funding Number: RFA CA 22 051
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R01 Clinical Trial Optional) Apply for RFA DA 23 061

Funding Number: RFA DA 23 061
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R21 Clinical Trial Not Allowed) Apply for RFA CA 22 057

Funding Number: RFA CA 22 057
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34 Clinical Trial Optional) Apply for RFA DA 23 062

Funding Number: RFA DA 23 062
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $450,000
Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R01 Clinical Trial Not Allowed) Apply for RFA CA 22 056

Funding Number: RFA CA 22 056
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional) Apply for PAR 23 034

Funding Number: PAR 23 034
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
AHEAD (Advancing Head and Neck Cancer Early Detection Research) (U01 Clinical Trial Not Allowed) Apply for RFA DE 23 013

Funding Number: RFA DE 23 013
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed) Apply for RFA DA 24 007

Funding Number: RFA DA 24 007
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) Apply for PAR 23 021

Funding Number: PAR 23 021
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional) Apply for PAR 22 249

Funding Number: PAR 22 249
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $2,000,000
Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed) Apply for PAR 22 239

Funding Number: PAR 22 239
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $375,000
Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Liquid Biopsy Research Laboratories (U01 Clinical Trial Not Allowed) Apply for RFA CA 23 018

Funding Number: RFA CA 23 018
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $600,000
Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed) Apply for PAR 23 041

Funding Number: PAR 23 041
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $125,000
Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit (U24 Clinical Trial Not Allowed) Apply for RFA CA 23 019

Funding Number: RFA CA 23 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $450,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 23 035", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: